Sign Up to like & get
recommendations!
0
Published in 2022 at "Experimental oncology"
DOI: 10.32471/exp-oncology.2312-8852.vol-44-no-1.17329
Abstract: BACKGROUND Approximately 15% to 24% of essential thrombocythemia (ET) and 25-35% of primary myelofibrosis cases carry a mutation in the calreticulin (CALR) gene. Sanger sequencing, qPCR, high resolution melt or targeted next generation sequencing usually…
read more here.
Keywords:
calr gene;
allele specific;
low cost;
mutation ... See more keywords